AbSci (ABSI) Stock Forecast & Price Target

Compare

1,008 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ABSI Analyst Ratings

Strong Buy

5 Buy

1 Hold

0 Sell

Based on 6 analysts giving stock ratings to

AbSci

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ABSI Stock 12 Month Forecast

Average Price Target

$6.38

▲(150.20% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for AbSci in the last 3 months. The average price target is $6.38 with a high forecast of $8.00 and a low forecast of $3.00. The average price target represents a 150.20% change from the last price of $2.55.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","3":"$3","5":"$5","7":"$7","9":"$9"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.38,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3,5,7,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.9,3.292307692307692,3.6846153846153844,4.076923076923077,4.469230769230769,4.861538461538461,5.253846153846154,5.646153846153846,6.038461538461538,6.430769230769231,6.823076923076923,7.215384615384615,7.607692307692307,{"y":8,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.9,3.167692307692308,3.4353846153846153,3.7030769230769227,3.9707692307692306,4.2384615384615385,4.506153846153846,4.773846153846153,5.041538461538462,5.309230769230769,5.576923076923077,5.844615384615384,6.1123076923076916,{"y":6.38,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.9,2.9076923076923076,2.9153846153846152,2.923076923076923,2.9307692307692306,2.9384615384615382,2.946153846153846,2.953846153846154,2.9615384615384617,2.9692307692307693,2.976923076923077,2.9846153846153847,2.9923076923076923,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.01,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.04,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.4,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.62,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.92,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.15,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.62,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.85,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.4,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.59,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.9,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$8.00

Average Price Target$6.38

Lowest Price Target$3.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Debanjana Chatterjee

JonesTrading

$9→$8

Buy

213.73%

Upside

Reiterated

08/20/25

Promising Potential of AbSci's ABS-201 Therapy for Androgenetic Alopecia: A Buy Recommendation

Dex Genotek

TR | OpenAI - 4o

Hold

17.65%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Sean Laaman

Morgan Stanley

$6.4→$5.89

Buy

130.98%

Upside

Reiterated

08/18/25

AbSci (ABSI) Gets a Buy from Morgan StanleyABSI.O ABSCI CORP Overweight with price target change from 6.40 to 5.89.

Swayampakula Ramakanth

H.C. Wainwright

Buy

174.51%

Upside

Reiterated

08/13/25

Promising Developments and Strong Financial Position Bolster AbSci's Growth ProspectsValuation and Risks. We maintain our Buy rating and 12-month price target of $7.00. We derive our price target based on a risk-adjusted net present value (rNPV) analysis of projected future revenues from Absci’s development programs with its partners, assuming a 10% discount rate and a 1% terminal growth rate. We derive an rNPV of $1.4B and add in net cash and cash equivalents of approximately $131M, to arrive at a 12-month price target of $6.83 per diluted share, which we round to $7.00.

Gil Blum

Needham

$9→$8

Buy

213.73%

Upside

Reiterated

08/13/25

AbSci's Positive Outlook: Strong Financial Position and Promising ABS-101 Developments Support Buy Rating9:24 AM 2025 PRICE TARGET & ESTIMATE CHANGE Biotechnology Absci Corporation (ABSI) RATING BUY PRICE TARGET $8.00 from $9.00 PREV CLOSE $2.97 52-WEEK RANGE $2.01 - $6.33 2Q:25 Absci reported 2Q:25 financial results. Initial results for ABS-101 in healthy volunteers are on track for 2H:25. A positive readout would provide initial POC for Absci's broader platform and make ABS-101 a potential target for large pharma. We maintain our Buy Rating and are lowering our after accounting for dilution from a recent financing.

Brendan Smith

TD Cowen

―

Buy

―

Reiterated

08/12/25

Buy Rating on AbSci: Strategic Developments and Undervalued Commercial Potential

George Farmer

Scotiabank

$13

Buy

409.80%

Upside

Reiterated

05/14/25

Scotiabank Keeps Their Buy Rating on AbSci (ABSI)

Unknown Analyst

Guggenheim

Not Ranked

Guggenheim

$10

Buy

292.16%

Upside

Reiterated

05/14/25

We remain Buy rated with a $10 price target.

Scott Schoenhaus

KeyBanc

$5→$9

Buy

252.94%

Upside

Reiterated

04/16/25

KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)

Srikripa Devarakonda

Truist Financial

―

Buy

―

Assigned

01/21/25

AbSci (ABSI) Gets a Buy from Truist Financial

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Debanjana Chatterjee

JonesTrading

$9→$8

Buy

213.73%

Upside

Reiterated

08/20/25

Promising Potential of AbSci's ABS-201 Therapy for Androgenetic Alopecia: A Buy Recommendation

Dex Genotek

TR | OpenAI - 4o

Hold

17.65%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Sean Laaman

Morgan Stanley

$6.4→$5.89

Buy

130.98%

Upside

Reiterated

08/18/25

AbSci (ABSI) Gets a Buy from Morgan StanleyABSI.O ABSCI CORP Overweight with price target change from 6.40 to 5.89.

Swayampakula Ramakanth

H.C. Wainwright

Buy

174.51%

Upside

Reiterated

08/13/25

Gil Blum

Needham

$9→$8

Buy

213.73%

Upside

Reiterated

08/13/25

Brendan Smith

TD Cowen

―

Buy

―

Reiterated

08/12/25

Buy Rating on AbSci: Strategic Developments and Undervalued Commercial Potential

George Farmer

Scotiabank

$13

Buy

409.80%

Upside

Reiterated

05/14/25

Scotiabank Keeps Their Buy Rating on AbSci (ABSI)

Unknown Analyst

Guggenheim

Not Ranked

Guggenheim

$10

Buy

292.16%

Upside

Reiterated

05/14/25

We remain Buy rated with a $10 price target.

Scott Schoenhaus

KeyBanc

$5→$9

Buy

252.94%

Upside

Reiterated

04/16/25

KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)

Srikripa Devarakonda

Truist Financial

―

Buy

―

Assigned

01/21/25

AbSci (ABSI) Gets a Buy from Truist Financial

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AbSci

1 Month

xxx

Success Rate

4/6 ratings generated profit

Average Return

+19.30%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +19.30% per trade.

3 Months

xxx

Success Rate

3/6 ratings generated profit

Average Return

+26.43%

reiterated a xxx

rating 5 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +26.43% per trade.

1 Year

Swayampakula RamakanthH.C. Wainwright

Success Rate

4/14 ratings generated profit

Average Return

+35.51%

reiterated a buy rating 16 days ago

Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of +35.51% per trade.

2 Years

xxx

Success Rate

4/14 ratings generated profit

Average Return

+8.91%

reiterated a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of +8.91% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ABSI Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ABSI has received 7 Buy Ratings, 11 Hold Ratings, and 1 Sell Ratings. ABSI average Analyst price target in the past 3 months is 6.38.

Each month's total comprises the sum of three months' worth of ratings.

ABSI Financial Forecast

ABSI Earnings Forecast

Next quarter’s earnings estimate for ABSI is -$0.19 with a range of -$0.23 to -$0.16. The previous quarter’s EPS was -$0.24. ABSI beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 50.00% of the time in the same period. In the last calendar year ABSI has Preformed in-line its overall industry.

ABSI Sales Forecast

Next quarter’s sales forecast for ABSI is $1.52M with a range of $700.00K to $2.00M. The previous quarter’s sales results were $593.00K. ABSI beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 55.07% of the time in the same period. In the last calendar year ABSI has Preformed in-line its overall industry.

ABSI Stock Forecast FAQ

What is ABSI’s average 12-month price target, according to analysts?

Based on analyst ratings, AbSci’s 12-month average price target is 6.38.

What is ABSI’s upside potential, based on the analysts’ average price target?

AbSci has 150.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is ABSI a Buy, Sell or Hold?

AbSci has a consensus rating of Strong Buy which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.

What is AbSci’s price target?

The average price target for AbSci is 6.38. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $8.00 ,the lowest forecast is $3.00. The average price target represents 150.20% Increase from the current price of $2.55.

What do analysts say about AbSci?

AbSci’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of ABSI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

AbSci (ABSI) Stock Forecast & Price Target

ABSI Analyst Ratings

ABSI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering AbSci

ABSI Analyst Recommendation Trends

ABSI Financial Forecast

ABSI Earnings Forecast

ABSI Sales Forecast

ABSI Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts